Clinical trial
Effect of Macugen(Pegaptanib)on Surgical Outcomes and VEGF Levels in Diabetic…
NCT00446381 · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's, Other · Completed
Key facts
| NCT number | NCT00446381 |
|---|---|
| Title | Effect of Macugen(Pegaptanib)on Surgical Outcomes and VEGF Levels in Diabetic Patients With PDR (Diabetic Retinopathy or CSDME (Macular Edema) |
| Official title | Effect of Macugen (Pegaptanib) on Surgical Outcomes and Growth Factors Including Vascular Endothelial Growth Factor (VEGF) Levels in Patients With Proliferative Diabetic Retinopathy (PDR) and Clinically Significant Diabetic Macular Edema (CSDME) |
| Acronym | PEGAP001 |
| Lead sponsor | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's, Other |
| Collaborators | Pfizer Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Proliferative Diabetic Retinopathy, Diabetic Macular Edema |
| Intervention type | Drug |
| Interventions | Macugen (pegaptanib), Macugen (Pegaptanib) |
| Enrollment | 28 |
| Start date | Oct 1, 2006 |
| Primary completion | Sep 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Mar 12, 2007 |
| Last update posted | Apr 19, 2012 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: